ILIraida Loinaz

Iraida Loinaz

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Iraida Loinaz has a total of 188 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Improved Epidermal Bioavailability and Anti-Inflammatory Activity of Cannabidiol Encapsulated in Polypeptide-Stabilised Emulsions

    by Paula Zamora, Janire Pikabea, Ángela Moncada-Pazos, Iraida Loinaz, Damien Dupin

    Cannabidiol (CBD) is a promising bioactive compound for skin applications; however, its topical delivery is limited by poor aqueous solubility, high lipophilicity, and chemical instability. Here, a polypeptide-stabilised oil-in-water emulsion enabling CBD encapsulation (ENC-CBD) was developed as an innovative delivery system to enhance the epidermal bioavailability and biological activity of CBD. Stable 216 nm ENC-CBD containing 175 mg/mL CBD exhibited long-term physicochemical stability over 18 months, maintaining CBD content, viscosity, density, and particle size within predefined specifications. Cytocompatibility studies in human keratinocytes (HaCaT) and dermal fibroblasts (HDF) showed concentration-dependent effects, with excellent biocompatibility at 1.75 mg/mL. In UVB-irradiated cellular models, ENC-CBD significantly reduced IL-6 and IL-8 production by 93% and 73%, respectively. Moreover, in reconstructed human epidermal tissues, ENC-CBD was non-irritant and achieved markedly greater epidermal CBD accumulation than non-encapsulated CBD, reaching approximately 11- and 7-fold higher levels after 6 h and 24 h, respectively. ENC-CBD applied to skin models significantly attenuated UV-induced inflammation characterised by overexpression of IL-6, IL-8, IL-1B, and TNF genes, while the delivery system appeared to have, to some extent, some anti-inflammatory properties. Overall, polypeptide-based emulsion carrier enhanced CBD epidermal delivery and its anti-inflammatory activity, highlighting its potential as a topical ingredient for skin inflammation.

  • 3D Printable Dynamic Hydrogel: As Simple as it Gets!

    by Aitor Díaz, Helena Herrada‐Manchón, Juliana Nunes, Aitziber Lopez, Natividad Díaz, Hans‐Jürgen Grande, Iraida Loinaz, Manuel Alejandro Fernández, Damien Dupin

    3D printing technology offers a vast range of applications for tissue engineering applications. Over the past decade a vast range of new equipment has been developed; while, 3D printable biomaterials, especially hydrogels, are investigated to fit the printability requirements. The current candidates for bioprinting often require post‐printing cross‐linking to maintain their shape. On the other hand, dynamic hydrogels are considered as the most promising candidate for this application with their extrudability and self‐healing properties. However, it proves to be very difficult to match the required rheological in a simple material. Here, this study presents for the first time the simplest formulation of a dynamic hydrogel based on thiol‐functionalized hyaluronic acid formulated with gold ions that fulfill all the requirements to be printed without the use of external stimuli, as judged by the rheological studies. The printability is also demonstrated with a 3D printer allowing for the printing of the dynamic hydrogel as it is, achieving 3D construct with a relatively good precision and up to 24 layers, corresponding to 10 mm high. This material is the simplest 3D printable hydrogel and its mixture with cells and biological compounds is expected to open a new era in 3D bioprinting.


  • Interfacial activity of modified dextran polysaccharide to produce enzyme-responsive oil-in-water nanoemulsions

    by Marcos Navascuez, Raquel Gracia, Marco Marradi, Natividad Díaz, Javier Rodríguez, Iraida Loinaz, Fernando López-Gállego, Jordi Llop, Damien Dupin

    The slight modification of dextran polysaccharides offers a new family of enzyme-responsive emulsifier for encapsulation and controlled release of hydrophobic molecules.


  • Single-Chain Polymer Nanoparticles for Application in Nanomedicine

    by Ibon Odriozola, Miren Karmele Aiertza, Germán Cabañero, Hans-Jürgen Grande, Iraida Loinaz

    This chapter discusses the synthetic strategies described in the literature and groups them into four main methods: homo-functional collapse, hetero-functional collapse, cross-linker-mediated collapse, and one-block collapse of diblock or triblock copolymers. It describes main characterization techniques and physical properties of single-chain polymeric nanoparticles. The role of nanoparticles in biomedicine has increased in recent years, mainly due to their wide number of applications in the field of nanomedicine. As a special case, there are also some reports on the use of diblock copolymers for the fabrication of nanoparticle-coil copolymers or molecular “tadpoles”. The strategy consists of functionalising just one of the blocks with reactive groups, so that when the intramolecular cross-linking is forced this block collapses into a globule, whereas the other block remains as a coil. The synthesis of discrete nanoparticles using a strategy that involves the intramolecular coupling of single polymer chains was proposed as early as in the 1980s.

  • COSAN-stabilised omega-3 oil-in-water nanoemulsions to prolong lung residence time for poorly water soluble drugs

    by Marcos Navascuez, Damien Dupin, Hans-Jürgen Grande, Vanessa Gómez-Vallejo, Iraida Loinaz, Unai Cossío, Jordi Llop

    Herein, we report on the capacity of the amphiphilic inorganic anion cobalt bis(dicarbollide) to stabilise oil-in-water nanoemulsions (NEs). The resulting NEs show long term stability in water and high drug-loading capacity, and can prolong the residence time of hydrophobic drugs in the lungs as determined by in vivo positron emission tomography imaging.


  • Open Access

    In vitro inhalation cytotoxicity testing of therapeutic nanosystems for pulmonary infection

    by Detlef Ritter, Jan Knebel, Monika Niehof, Iraida Loinaz, Marco Marradi, Raquel Gracia, Yvonne Te Welscher, Cornelus F. van Nostrum, Chiara Falciani, Alessandro Pini, et al.


  • Technological challenges in the preclinical development of an HIV nanovaccine candidate

    by Tamara G. Dacoba, Luisa Ruiz-Gatón, Ana Benito, Marlène Klein, Damien Dupin, Ma Luo, Mathieu Menta, Desirée Teijeiro-Osorio, Iraida Loinaz, María J. Alonso, et al.

    Despite a very active research in the field of nanomedicine, only a few nano-based drug delivery systems have reached the market. The “death valley” between research and commercialization has been partially attributed to the limited characterization and reproducibility of the nanoformulations. Our group has previously reported the potential of a peptide-based nanovaccine candidate for the prevention of SIV infection in macaques. This vaccine candidate is composed of chitosan/dextran sulfate nanoparticles containing twelve SIV peptide antigens. The aim of this work was to rigorously characterize one of these nanoformulations containing a specific peptide, following a quality-by-design approach. The evaluation of the different quality attributes was performed by several complementary techniques, such as dynamic light scattering, nanoparticle tracking analysis, and electron microscopy for particle size characterization. The inter-batch reproducibility was validated by three independent laboratories. Finally, the long-term stability and scalability of the manufacturing technique were assessed. Overall, these data, together with the in vivo efficacy results obtained in macaques, underline the promise this new vaccine holds with regard to its translation to clinical trials.


  • Open Access

    Antimicrobial Peptide-Loaded Nanoparticles as Inhalation Therapy for Pseudomonas aeruginosa Infections

    by Chiara Falciani, Fabrizia Zevolini, Jlenia Brunetti, Giulia Riolo, Raquel Gracia, Marco Marradi, Iraida Loinaz, Christina Ziemann, Unai Cossío, Jordi Llop, et al.

    Introduction: Antibiotic-resistant bacteria kill 25,000 people every year in the EU. Patients subject to recurrent lung infections are the most vulnerable to severe or even lethal infections. For these patients, pulmonary delivery of antibiotics would be advantageous, since inhalation can achieve higher concentration in the lungs than iv administration and can provide a faster onset of action. This would allow for the delivery of higher doses and hence reduce the number of treatments required. We report here about a new nanosystem (M33-NS) obtained by capturing SET-M33 peptide on single-chain dextran nanoparticles. SET-M33 is a non-natural antimicrobial peptide synthesized in branched form. This form gives the peptide resistance to degradation in biological fluids. SET-M33 has previously shown efficacy in vitro against about one hundred of Gram-negative multidrug and extensively drug-resistant clinical isolates and was also active in preclinical infection models of pneumonia, sepsis and skin infections. Methods: The new nanosystem was evaluated for its efficacy in bacteria cells and in a mouse model of pneumonia. Toxicity and genotoxicity were also tested in vitro. Biodistribution and pharmacokinetic studies in healthy rats were carried out using a radiolabeled derivative of the nanosystem. Results: The M33-nanosystem, studied here, showed to be effective against Pseudomonas aeruginosa in time-kill kinetic experiments. Cytotoxicity towards different animal cell lines was acceptable. Lung residence time of the antimicrobial peptide, administered via aerosol in healthy rats, was markedly improved by capturing SET-M33 on dextran nanoparticles. M33-NS was also efficient in eradicating pulmonary infection in a BALB/c mouse model of pneumonia caused by P. aeruginosa. Discussion: This study revealed that the encapsulation of the antimicrobial peptide in dextran nanoparticles markedly improved lung residence time of the peptide administered via aerosol. The result has to be considered among the aims of the development of a new therapeutic option for patients suffering recurrent infections, that will benefit from high local doses of persistent antimicrobials.


  • Advanced nanomedicine characterization by DLS and AF4-UV-MALS: Application to a HIV nanovaccine

    by Marlène Klein, Mathieu Menta, Tamara G. Dacoba, José Crecente-Campo, María J. Alonso, Damien Dupin, Iraida Loinaz, Bruno Grassl, Fabienne Séby


  • Biocompatible single-chain polymer nanoparticles loaded with an antigen mimetic as potential anticancer vaccine

    by Raquel Gracia, Marco Marradi, Gianluca Salerno, Rocmira Pérez-Nicado, Adrián Pérez-San Vicente, Damien Dupin, Javier Rodriguez, Iraida Loinaz, Fabrizio Chiodo, Cristina Nativi

    The “pancarcinoma” Tn antigen (αGalNAc-O-Ser/Thr) is a tumor-associated carbohydrate antigen (TACA) overexpressed on the surface of cancer cells and suitable target for anticancer vaccines. However, TACAs commonly show weak immunogenicity, low in vivo stability, and poor bioavailability. To address these issues, the development of physiologically stable TACA synthetic mimetics and novel nanocarriers for multivalent display are object of intense research. Nanomaterials represent suitable scaffolds to multimerize antigens, but absence of toxicity, easy functionalization and capability to incorporate biomolecules are compulsory characteristics for vaccine nanocarriers. Here, we report on the conjugation of a synthetic Tn-antigen mimetic to biocompatible and water-dispersible dextran-based single-chain nanoparticles (DXT-SCPNs). In vitro stimulation of PBMCs and analysis of interleukins production indicated a specific innate immune modulation mediated by the multivalent presentation of the Tn mimetic at the nanoparticle surface. These preliminary results pave the way for the development of Tn-mimetic clusters on biocompatible DXT-SCPN for TACA-based vaccines.